Effect of alkaline water in treatment of gastroesophageal reflux

Evaluation of the therapeutic effect of alkaline water in patients with gastroesophageal reflux disease

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20190305042935N2

Enrollment

Registered

2020-03-14

Start date

2019-05-31

Completion date

Unknown

Last updated

2020-03-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gastroesophageal reflux disease. Gastro-esophageal reflux disease

Interventions

Intervention 1: Intervention group: This group will receive at least 1.3 liters of alkaline water (bottle A) daily regardless of specific consumption pattern and based on routine consumption. For the

Eligibility

Sex/Gender

All

Age

18 Years to 40 Years

Inclusion criteria

Inclusion criteria: Symptoms of gastroesophageal reflux disease at least 2 times a week for at least 3 months Age between 18 to 40 years

Exclusion criteria

Exclusion criteria: Any pathological problem associated with gastroesophageal reflux disease including Barrett's esophagus and malignancy Having warning signs such as painful and difficulty swallowing, nausea, vomiting and fever

Design outcomes

Primary

Measure	Time frame
Mean scores of gastrointestinal symptoms in GERD questionnaire. Timepoint: Before the intervention and six-week after intervention. Method of measurement: Gastroesophageal Reflux Disease (GERD) questionnaire.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDoctor Ghorbanali Rahimian

Shahre-kord University of Medical Sciences

ghorbanali.rahimian@gmail.com+98 38 3333 5653

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026